PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 
	Make sure your email is up-to-date
	In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to cmichalek@ismp.org. 
     
  
  
  
  
    
      Fri, 03/21/2025 - 11:45
                
    
    
        
    #1
    
  
    
              
 
        
            
        Mary Soliman      
                    
  
      
                    
           Offline        
      
                    
           Last seen: 3 months 12 hours ago        
      
            
            
                    
          Joined: 08/04/2024 - 15:40        
      
            
                 
        
            
            
            
                
        
            
              
   
 
           
    
              
          Levemir Discontinuation         
      
      
        
  
    How are systems handling the transition away from Levemir, particularly with home medications being continued in house and upon discharge if patient still have supply at home? Trying to deter in-patient continuation and discharge on this medication. Thanks in advance!